Poonnawis Sudtikoonaseth
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Poonnawis Sudtikoonaseth has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Chanisa Kiatsurayanon
Institute of Dermatology Bangkok Thailand
1 shared publication - Chayamon Takpradit
Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
1 shared publication - Kowit Kampirapap
Institute of Dermatology, Bangkok
1 shared publication - Manasmon Chairatchaneeboon
Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, THAILAND
1 shared publication - Monton Tanabodee
Division of Dermatology, Department of Internal Medicine, Suphan Buri
1 shared publication - Natsuda Sajjachareonpong
Institute of Dermatology, Bangkok
1 shared publication
Latest Publications
- Open Access
- 12 February 2025
- Published by PAGEPress Publications in Dermatology Reports
- Vol. 17 (3)
Lucio phenomenon: a case report on an overlooked reaction in lepromatous leprosy
Our patient presented with a 5-year history of chronic, asymptomatic papulonodular lesions on the extremities. Over the past 8 months, the lesions have spread to the face and earlobes, and new ulcerative lesions have appeared on both legs. Skin biopsy was compatible with lepromatous leprosy with Lucio phenomenon. Lucio phenomenon is a rare type of leprosy reaction found mostly in neglected lepromatous leprosy cases. Unfortunately, the patient developed pulmonary embolism and passed away. This case report focuses on the clinicopathological characteristics and management of Lucio phenomenon, which is an unusual form of leprosy reaction that often carries a poorer prognosis. Importantly, physicians should be able to differentiate the Lucio phenomenon from other types of leprosy reactions for prompt management.
- 12 February 2025
- Published by PAGEPress Publications in Dermatology Reports
- Vol. 17 (3)
Open AccessLucio phenomenon: a case report on an overlooked reaction in lepromatous leprosy
Our patient presented with a 5-year history of chronic, asymptomatic papulonodular lesions on the extremities. Over the past 8 months, the lesions have spread to the face and earlobes, and new ulcerative lesions have appeared on both legs. Skin biopsy was compatible with lepromatous leprosy with Lucio phenomenon. Lucio phenomenon is a rare type of leprosy reaction found mostly in neglected lepromatous leprosy cases. Unfortunately, the patient developed pulmonary embolism and passed away. This case report focuses on the clinicopathological characteristics and management of Lucio phenomenon, which is an unusual form of leprosy reaction that often carries a poorer prognosis. Importantly, physicians should be able to differentiate the Lucio phenomenon from other types of leprosy reactions for prompt management.
- Open Access
- 30 September 2022
- Published by MDPI AG in Dermatopathology
- Vol. 9 (4) , 321-326
A Rare Case of Blastic Plasmacytoid Dendritic Cell Neoplasm in a Child Mimicking Lymphoma/Leukemia Cutis
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare tumor that affects elderly individuals and presents a poor prognosis. Skin is the most common site of involvement, accounting for 89% of the cases. Extracutaneous organs, especially bone marrow, lymph nodes, and peripheral blood, can be involved at the time of diagnosis. We report a case of BPDCN in a child, presenting with a cutaneous lesion mimicking lymphoma or leukemia cutis. The histologic findings revealed a dense diffuse infiltration by monomorphic agranular medium-sized blast cells with sparing of the grenz zone, whose first immunophenotypic profile raised the possibility of diagnosing B lymphoblastic lymphoma or leukemia. However, the absence of CD10 expression and strongly positive expression for CD4, CD56, CD45RA, and the plasmacytoid dendritic cell-associated antigens, including CD123, supported the definite diagnosis of BPDCN. The patient responded well to a systemic combination chemotherapy regimen, modified from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) protocol for anaplastic large cell lymphoma (ALCL), that differed from the established recommendation using ALL protocol. Owing to the patient’s excellent treatment outcome, this regimen could represent an effective alternative regimen for BPDCN in children.
- 30 September 2022
- Published by MDPI AG in Dermatopathology
- Vol. 9 (4) , 321-326
Open AccessA Rare Case of Blastic Plasmacytoid Dendritic Cell Neoplasm in a Child Mimicking Lymphoma/Leukemia Cutis
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare tumor that affects elderly individuals and presents a poor prognosis. Skin is the most common site of involvement, accounting for 89% of the cases. Extracutaneous organs, especially bone marrow, lymph nodes, and peripheral blood, can be involved at the time of diagnosis. We report a case of BPDCN in a child, presenting with a cutaneous lesion mimicking lymphoma or leukemia cutis. The histologic findings revealed a dense diffuse infiltration by monomorphic agranular medium-sized blast cells with sparing of the grenz zone, whose first immunophenotypic profile raised the possibility of diagnosing B lymphoblastic lymphoma or leukemia. However, the absence of CD10 expression and strongly positive expression for CD4, CD56, CD45RA, and the plasmacytoid dendritic cell-associated antigens, including CD123, supported the definite diagnosis of BPDCN. The patient responded well to a systemic combination chemotherapy regimen, modified from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) protocol for anaplastic large cell lymphoma (ALCL), that differed from the established recommendation using ALL protocol. Owing to the patient’s excellent treatment outcome, this regimen could represent an effective alternative regimen for BPDCN in children.